The Fiscal Year 2027 Department of Health and Human Services Budget

Treasury and HHS ConfirmationsHouse Energy and Commerce Subcommittee on Health · 2026-04-21 · 119th Congress
The House Energy and Commerce Subcommittee on Health convened to examine the Department of Health and Human Services' fiscal year 2027 budget request, with Secretary Robert F. Begins at 0:22:59
Transcript
Highlights

Title

Secretary Kennedy defends HHS budget amid vaccine, Medicaid disputes

Purpose

The House Energy and Commerce Subcommittee on Health convened to examine the Department of Health and Human Services' fiscal year 2027 budget request, with Secretary Robert F. Kennedy Jr. testifying on department priorities including drug pricing, rural health funding, waste/fraud/abuse enforcement, and vaccine policy. The hearing featured sharp partisan exchanges over Medicaid funding changes, the elimination of maternal health and family planning programs, and Kennedy's record on vaccine policy amid a measles outbreak. Begins at0:22:59

Who spoke

Rep. Diana Harshbarger (R-TN), Subcommittee Chair0:22:59: Opened praising the administration's "Make America Healthy Again" agenda, price transparency, and rural health focus0:23:24; later pressed Kennedy on 340B program reform, calling it a "boondoggle" that has grown from 90 to 12,000 entities1:21:441:22:29.

Rep. Diana DeGette (D-CO), Ranking Member0:27:05: Criticized the firing of ACIP members, cancellation of mRNA research, and Tylenol pregnancy warnings0:28:48; described a Colorado HIV-prevention program halted by funding instability0:30:04.

Rep. Brett Guthrie (R-KY), Full Committee Chairman0:32:18: Commended new dietary guidelines and anti-fraud efforts0:32:42; questioned Kennedy on the Rural Health Transformation Fund0:56:35 and Medicaid fraud discoveries, including a Florida hotel where all 129 rooms were fraudulent durable medical equipment companies1:00:13.

Rep. Frank Pallone (D-NJ), Full Committee Ranking Member0:34:20: Said HHS actions and the "big, ugly bill" have driven up costs and coverage losses0:34:40, citing 15 million Americans expected to lose coverage0:35:32; sparred with Kennedy over funding health care versus the Iran war1:02:29.

Secretary Robert F. Kennedy Jr., HHS Secretary0:39:33: Touted a most-favored-nation drug pricing deal with 16 pharmaceutical companies0:40:52, the $50 billion Rural Health Transformation Fund0:43:34, and denied Medicaid cuts, citing a 47% spending increase over ten years1:04:15; defended his vaccine record, denying being "anti-vaccine"1:19:55.

Rep. Raul Ruiz (D-CA)1:13:46: Questioned Kennedy on CDC director nominee Erica Schwartz's pro-vaccine statements1:14:16 and the firing of prior CDC Director Susan Monarez1:15:18; cited polling showing 55% disapproval of Kennedy's work1:18:06.

Rep. Earl "Buddy" Carter (R-GA)1:19:25: Gave Kennedy time to respond to prior criticism1:19:55; asked about 340B reform and pharmaceutical domestic manufacturing investments, including $325 million for API reshoring1:24:54.

Rep. Debbie Dingell (D-MI)1:25:26: Described measles outbreaks in her county tied to vaccine hesitancy1:26:19; pressed Kennedy on rescinding nursing home minimum staffing standards and a New York Times report on donor lunches at Mar-a-Lago1:29:56.

Rep. John Joyce (R-PA)1:30:43: Praised anti-fraud initiatives and organ procurement oversight reforms1:31:41; raised concerns about Stark Law enforcement on physician compensation and radiation oncology reimbursement cuts1:32:541:34:18.

Rep. Robin Kelly (D-IL)1:39:53: Pressed Kennedy repeatedly on whether a $900 billion Medicaid funding reduction constitutes a "cut"1:40:19; entered a Newsweek article on an Elk Grove Village obstetrics unit closure into the record1:43:30.

Rep. Troy Balderson (R-OH)1:45:06: Asked about wearable technology for chronic disease detection1:45:33 and Alzheimer's screening via the U.S. Preventive Services Task Force1:47:46.

Rep. Nanette Barragán (D-CA)1:50:18: Raised Medicaid/Medicare glucose meter coverage barriers1:50:18; pressed Kennedy on Title X elimination's effect on birth control access1:51:42 and a $312 million cut to Alzheimer's research at the National Institute on Aging1:53:13.

Rep. Mariannette Miller-Meeks (R-IA)1:55:52: Discussed her over-the-counter oral contraception bill1:56:09 and the WALTZ Act targeting welfare fraud1:56:39; noted Iowa was first state to disburse Rural Health Transformation funds1:59:14.

Rep. Kim Schrier (D-WA)2:00:56: Challenged Kennedy's new hepatitis B vaccine recommendation, citing a 1-2% test false-negative rate2:01:27; linked his vaccine rhetoric to parents refusing newborn vitamin K shots, calling it the "RFK Jr. spillover effect"2:03:11.

Rep. Kat Cammack (R-FL)2:06:03: Praised trusting parents' medical decisions2:06:34; secured commitment from Kennedy to oppose QALY-based coverage discrimination2:10:01 and discussed FDA AI-driven review speed improvements2:11:00.

Rep. Lori Trahan (D-MA)2:11:30: Disputed Kennedy's claim that only ineligible people lost ACA coverage, citing 1.2 million who lost coverage2:11:58; argued higher premiums shrink insurance risk pools2:14:19.

Rep. John James (R-MI)2:16:35: Praised Kennedy's price transparency enforcement efforts2:17:25; raised Lyme disease testing accuracy concerns based on his family's experience2:19:15.

Rep. Dan Bentz? (R-OR)2:26:38: (Rep. Bentz) Discussed a proposed ACA exchange reference-pricing rule2:27:02 and cited a $1,300–$22,000 price range for the same delivery procedure across New York hospitals2:28:17.

Rep. Lizzie Fletcher (D-TX)2:32:01: Pressed Kennedy on NIH job losses (391,000 American jobs tied to NIH funding)2:33:44 and delayed funding opportunity notices — 8 issued versus 84 in 20242:36:44.

Rep. Max Miller? / Rep. Rowley2:37:13: Raised FDA reclassification of desiccated thyroid extract as a biologic, threatening compounding access2:38:06.

Rep. Alexandria Ocasio-Cortez (D-NY)2:41:21: Challenged Kennedy on a $13 billion Medicare Advantage reimbursement increase to insurers accused of $80 billion in annual fraud2:42:16.

Rep. Erin Houchin (R-IN)2:47:05: Asked about accelerating FDA approval for domestic pharmaceutical precursor manufacturing, citing a Chinese-sourced fludarabine phosphate precursor2:48:16; raised long COVID research needs2:50:30.

Rep. Jake Auchincloss (D-MA)2:52:23: Alleged FDA politicization, citing whistleblower quotes from career scientists2:53:19 and a Commissioner's National Priority Voucher issued for psychedelics reportedly following a Trump-Joe Rogan text exchange2:55:08.

Rep. Nick Langworthy (R-NY)2:57:51: Asked about advanced explanation-of-benefits tools and price transparency enforcement, noting HHS sent 1,000 compliance letters3:00:27; discussed biosimilar approval acceleration3:01:21.

Rep. Buddy Carter (R-GA), second round3:02:37: Pressed Kennedy on SAMHSA's erroneous January 13 cancellation of $2 billion in grant funding, later reversed within 24 hours3:03:23.

Rep. Greg Landsman (D-OH)3:07:42: Disputed Kennedy's "no Medicaid cuts" claim against CBO estimates of roughly $1 trillion in reductions3:09:07; questioned the $13 billion Medicare Advantage rate increase versus redirecting enrollees to traditional Medicare3:11:22.

Key moments

Kennedy stated the U.S. had about 2,200 measles cases last year and 1,700 this year, comparing favorably to Mexico, Canada, and Europe on a per-capita basis0:47:21.

DeGette confirmed Kennedy is proposing to eliminate the CDC Safe Motherhood program entirely, not restructure it0:52:25; Kennedy declined to commit to preserving access to any birth control method of choice0:55:13.

Kennedy repeatedly asserted "no cuts to Medicaid," citing a 47% spending increase over ten years, while multiple Democrats (Kelly, Trahan, Landsman) cited CBO estimates of roughly $900 billion to $1 trillion in federal Medicaid funding reductions1:40:192:44:113:09:30.

Kennedy described Medicaid fraud findings including autism/ABA therapy billing that rose from $7 million to $200 million a year in one state, "most of that was stolen"0:59:46, and a Florida hotel where all 129 rooms were fraudulent DME companies1:00:13.

Schrier and Kennedy clashed over the new hepatitis B birth-dose policy; Schrier said a 1-2% test false-negative rate combined with the change could leave newborns of undiagnosed mothers with a 90% chance of chronic hepatitis B2:01:50.

Ocasio-Cortez pressed Kennedy on approving a $13 billion Medicare Advantage reimbursement increase (revised from a proposed 0.09% raise to 2.48%) despite insurers allegedly defrauding the public of $80 billion annually through upcoding2:42:162:45:08.

Auchincloss alleged the FDA issued three psychedelic-drug priority review vouchers following a text exchange between Joe Rogan and President Trump, and cited internal whistleblower complaints of political pressure at FDA2:55:08.

Rep. Carter pressed Kennedy on SAMHSA's erroneous January 13 termination letter to roughly 2,000 grantees for mental health and substance use programs, cancelling nearly $2 billion, which was withdrawn within 24 hours3:03:23.

Kennedy said newly negotiated "most favored nation" drug pricing deals with 16 pharmaceutical companies mean Americans "no longer pay more than people in other wealthy countries" for the same medications0:40:52.

Fletcher noted NIH issued only 8 notices of funding opportunity in the administration's first 13 months compared to 84 in 2024, while Kennedy acknowledged the budget proposes capping indirect research costs at 15%2:36:44.

Metadata

CommitteeHouse Energy and Commerce Subcommittee on Health
Chamber / CongressHouse · 119th Congress
Date2026-04-21
TypeHearing
Witnesses
The Honorable Robert F. Kennedy, Jr. — Secretary, U.S. Department of Health and Human Services
Videoyoutube
Transcript382 caption blocks · 26,798 words · 3:13:51 runtime
EventCongress.gov 119213